JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406205200 on September 7, 2004

J. Biol. Chem., Vol. 279, Issue 46, 48255-48261, November 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/46/48255    most recent
M406205200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, H.
Right arrow Articles by Lefkowitz, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, H.
Right arrow Articles by Lefkowitz, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stable Interaction between {beta}-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for {beta}-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2*

Huijun Wei{ddagger}, Seungkirl Ahn{ddagger}, William G. Barnes{ddagger}, and Robert J. Lefkowitz, Investigator of the Howard Hughes Medical Institute{ddagger}§

From the {ddagger}Howard Hughes Medical Institute, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

Binding of {beta}-arrestins to seven-membrane-spanning receptors (7MSRs) not only leads to receptor desensitization and endocytosis but also elicits additional signaling processes. We recently proposed that stimulation of the angiotensin type 1A (AT1A) receptor results in independent {beta}-arrestin 2- and G protein-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation. Here we utilize two AT1A mutant receptors to study these independent pathways, one truncated at residue 324, thus removing all potential carboxyl-terminal phosphorylation sites, and the other bearing four mutations in the serine/threonine-rich clusters in the carboxyl terminus. As assessed by confocal microscopy, the two mutant receptors interacted with {beta}-arrestin 2-green fluorescent protein with much lower affinity than did the wild-type receptor. In addition, the mutant receptors more robustly stimulated G protein-mediated inositol phosphate production. Approximately one-half of the wild-type AT1A receptor-stimulated ERK1/2 activation was via a {beta}-arrestin 2-dependent pathway (suppressed by {beta}-arrestin 2 small interfering RNA), whereas the rest was mediated by a G protein-dependent pathway (suppressed by protein kinase C inhibitor). ERK1/2 activation by the mutant receptors was insensitive to {beta}-arrestin 2 small interfering RNA but was reduced more than 80% by a protein kinase C inhibitor. The biochemical consequences of ERK activation by the G protein and {beta}-arrestin 2-dependent pathways were also distinct. G-protein-mediated ERK activation enhanced the transcription of early growth response 1, whereas {beta}-arrestin 2-dependent ERK activation did not. In addition, stimulation of the truncated AT1A mutant receptor caused significantly greater early growth response 1 transcription than did the wild-type receptor. These findings demonstrate how the ability of receptors to interact with {beta}-arrestins determines both the mechanism of ERK activation as well as the physiological consequences of this activation.


Received for publication, June 3, 2004 , and in revised form, August 30, 2004.

* This work was supported by National Institutes of Health Grants RO1 HL16037 and HL70631 (to R. J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Howard Hughes Medical Inst., Depts. of Medicine and Biochemistry, Box 3821, Duke University Medical Ctr., Durham, NC 27710. Tel.: 919-684-2974; Fax: 919-684-8875; E-mail: lefko001{at}receptor-biol.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M.-H. Lee, H. M. El-Shewy, D. K. Luttrell, and L. M. Luttrell
Role of -Arrestin-mediated Desensitization and Signaling in the Control of Angiotensin AT1a Receptor-stimulated Transcription
J. Biol. Chem., January 25, 2008; 283(4): 2088 - 2097.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. Rozenfeld and L. A. Devi
Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers
FASEB J, August 1, 2007; 21(10): 2455 - 2465.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Violin, S. M. DeWire, W. G. Barnes, and R. J. Lefkowitz
G Protein-coupled Receptor Kinase and beta-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics
J. Biol. Chem., November 24, 2006; 281(47): 36411 - 36419.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. T. Drake, S. K. Shenoy, and R. J. Lefkowitz
Trafficking of G Protein-Coupled Receptors
Circ. Res., September 15, 2006; 99(6): 570 - 582.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. J. Braszko, A. Walesiuk, and P. Wielgat
Cognitive Effects Attributed to Angiotensin II may Result from its Conversion to Angiotensin IV
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 168 - 174.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Billet, S. Bardin, R. Tacine, E. Clauser, and S. Conchon
The AT1A receptor "gain-of-function" mutant N111S/{Delta}329 is both constitutively active and hyperreactive to angiotensin II
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E840 - E848.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
S. K. Shenoy and R. J. Lefkowitz
Angiotensin II-Stimulated Signaling Through G Proteins and {beta}-Arrestin
Sci. Signal., November 22, 2005; 2005(311): cm14 - cm14.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Gesty-Palmer, H. E. Shewy, T. A. Kohout, and L. M. Luttrell
{beta}-Arrestin 2 Expression Determines the Transcriptional Response to Lysophosphatidic Acid Stimulation in Murine Embryo Fibroblasts
J. Biol. Chem., September 16, 2005; 280(37): 32157 - 32167.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y.-H. Feng, Y. Ding, S. Ren, L. Zhou, C. Xu, and S. S. Karnik
Unconventional Homologous Internalization of the Angiotensin II Type-1 Receptor Induced by G-Protein-Independent Signals
Hypertension, August 1, 2005; 46(2): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Willoughby and M. K. Collins
Dynamic Interaction between the Dual Specificity Phosphatase MKP7 and the JNK3 Scaffold Protein {beta}-Arrestin 2
J. Biol. Chem., July 8, 2005; 280(27): 25651 - 25658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor C Terminus Modulates {beta}-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation
J. Biol. Chem., June 10, 2005; 280(23): 22124 - 22134.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.